HK143095A - Imidazoline derivative and preparation thereof - Google Patents

Imidazoline derivative and preparation thereof

Info

Publication number
HK143095A
HK143095A HK143095A HK143095A HK143095A HK 143095 A HK143095 A HK 143095A HK 143095 A HK143095 A HK 143095A HK 143095 A HK143095 A HK 143095A HK 143095 A HK143095 A HK 143095A
Authority
HK
Hong Kong
Prior art keywords
preparation
imidazoline derivative
group
erythemathodes
immunomodulator
Prior art date
Application number
HK143095A
Other languages
English (en)
Inventor
Kazuo Matsumoto
Mamoru Suzuki
Kozo Yamamoto
Isao Takata
Yoshio Iwasawa
Original Assignee
Tanabe Seiyaku Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tanabe Seiyaku Co filed Critical Tanabe Seiyaku Co
Publication of HK143095A publication Critical patent/HK143095A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/20—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
HK143095A 1988-10-06 1995-09-07 Imidazoline derivative and preparation thereof HK143095A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP63253391A JPH02101065A (ja) 1988-10-06 1988-10-06 イミダゾリン誘導体及びその製法

Publications (1)

Publication Number Publication Date
HK143095A true HK143095A (en) 1995-09-15

Family

ID=17250719

Family Applications (1)

Application Number Title Priority Date Filing Date
HK143095A HK143095A (en) 1988-10-06 1995-09-07 Imidazoline derivative and preparation thereof

Country Status (17)

Country Link
US (1) US5051441A (sv)
EP (1) EP0363061B1 (sv)
JP (1) JPH02101065A (sv)
KR (1) KR960009570B1 (sv)
CN (1) CN1020096C (sv)
AT (1) ATE78470T1 (sv)
AU (1) AU611827B2 (sv)
CA (1) CA1330997C (sv)
DE (1) DE68902209T2 (sv)
DK (1) DK491489A (sv)
ES (1) ES2052015T3 (sv)
FI (1) FI94632C (sv)
GR (1) GR3005779T3 (sv)
HK (1) HK143095A (sv)
HU (1) HU202211B (sv)
IE (1) IE61924B1 (sv)
IL (1) IL91704A0 (sv)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL92441A (en) * 1988-12-07 1993-05-13 Tanabe Seiyaku Co Imidazole containing peptides, their preparation and pharmaceutical compositions containing them
GB9020889D0 (en) * 1990-09-25 1990-11-07 May & Baker Ltd New compositions of matter
JP2564380Y2 (ja) * 1993-12-10 1998-03-09 大阪瓦斯株式会社 締付トルク確認継手
DE19540027A1 (de) * 1995-10-27 1997-04-30 Gruenenthal Gmbh Substituierte Imidazolidin-2,4-dion-Verbindungen als pharmazeutische Wirkstoffe
KR100426204B1 (ko) * 1998-05-23 2004-06-24 문승자 합성수지판제조방법
US6365616B1 (en) 1998-08-31 2002-04-02 Sentron Medical, Inc. Methimazole derivatives and tautomeric cyclic thiones to treat autoimmune diseases
US20020142974A1 (en) * 1998-09-11 2002-10-03 Leonard D. Kohn Immune activation by double-stranded polynucleotides
EP1463501B1 (en) 2001-12-18 2008-06-11 F. Hoffmann-La Roche AG Cis-imidazolines as mdm2 inhibitors
EP1643989B1 (en) * 2003-06-17 2010-04-28 F. Hoffmann-La Roche Ag Cis-imidazolines as mdm2 inhibitors
US7425638B2 (en) 2003-06-17 2008-09-16 Hoffmann-La Roche Inc. Cis-imidazolines
US7132421B2 (en) 2003-06-17 2006-11-07 Hoffmann-La Roche Inc. CIS-imidazoles
ATE414693T1 (de) 2004-05-18 2008-12-15 Hoffmann La Roche Neuartige cis-imidazoline
US7893278B2 (en) 2004-06-17 2011-02-22 Hoffman-La Roche Inc. CIS-imidazolines
EP1768662A2 (en) 2004-06-24 2007-04-04 Novartis Vaccines and Diagnostics, Inc. Small molecule immunopotentiators and assays for their detection
EP2130822A1 (en) 2005-12-01 2009-12-09 F. Hoffmann-La Roche AG 2,4,5-triphenyl imidazoline derivatives as inhibitors of the interaction between p53 and mdm2 proteins for use as anticancer agents
CN101370799B (zh) 2006-01-18 2012-09-05 霍夫曼-拉罗奇有限公司 作为mdm2抑制剂的顺-4,5-二芳基-2-杂环-咪唑啉
US7625895B2 (en) 2007-04-12 2009-12-01 Hoffmann-Le Roche Inc. Diphenyl-dihydro-imidazopyridinones
CN104710408A (zh) 2007-10-09 2015-06-17 霍夫曼-拉罗奇有限公司 手性顺式-咪唑啉类
US8252942B2 (en) * 2007-10-09 2012-08-28 Board Of Trustees Of Michigan State University Substituted imidazoline compounds
CA2933018C (en) * 2014-01-29 2021-10-26 Toray Industries, Inc. Therapeutic or prophylactic agent for multiple sclerosis

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH44279A (fr) * 1908-03-09 1909-07-16 Anonima Per Frigorigeni E Moto Appareil pour l'échange de chaleur entre des fluides sous pression
NL296772A (sv) * 1962-03-21
GB1047569A (en) * 1962-10-31 1966-11-09 Du Pont Light-sensitive compositions
US3707475A (en) * 1970-11-16 1972-12-26 Pfizer Antiinflammatory imidazoles
EP0005219B1 (en) * 1978-04-24 1981-07-22 A/S Dumex (Dumex Ltd.) Arylimidazoles, their synthesis and pharmaceutical or veterinary preparations containing them
US4424229A (en) * 1979-04-23 1984-01-03 A/S Dumex (Dumex Ltd.) Fluorine containing 2,4,5-triphenylimidazoles
US4252887A (en) * 1979-08-14 1981-02-24 E. I. Du Pont De Nemours And Company Dimers derived from unsymmetrical 2,4,5-triphenylimidazole compounds as photoinitiators
DE3141063A1 (de) * 1981-10-13 1983-04-28 Schering Ag, 1000 Berlin Und 4619 Bergkamen Neue imidazol-derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate
GB8906198D0 (en) * 1989-03-17 1989-05-04 Ciba Geigy Ag Compounds

Also Published As

Publication number Publication date
JPH02101065A (ja) 1990-04-12
IE61924B1 (en) 1994-11-30
HU202211B (en) 1991-02-28
FI894693A0 (sv) 1989-10-04
JPH0581592B2 (sv) 1993-11-15
DK491489D0 (da) 1989-10-05
HU895226D0 (en) 1990-01-28
IL91704A0 (en) 1990-06-10
AU4236889A (en) 1990-04-12
IE892977L (en) 1990-04-06
FI94632C (sv) 1995-10-10
CN1041760A (zh) 1990-05-02
HUT51601A (en) 1990-05-28
GR3005779T3 (sv) 1993-06-07
DK491489A (da) 1990-04-07
EP0363061B1 (en) 1992-07-22
KR900006296A (ko) 1990-05-07
US5051441A (en) 1991-09-24
EP0363061A1 (en) 1990-04-11
DE68902209D1 (de) 1992-08-27
FI894693A (sv) 1990-04-07
FI94632B (sv) 1995-06-30
DE68902209T2 (de) 1992-12-10
ATE78470T1 (de) 1992-08-15
KR960009570B1 (ko) 1996-07-20
ES2052015T3 (es) 1994-07-01
AU611827B2 (en) 1991-06-20
CA1330997C (en) 1994-07-26
CN1020096C (zh) 1993-03-17

Similar Documents

Publication Publication Date Title
GR3005779T3 (sv)
IL107426A0 (en) Heterocyclic compounds, processes for the preparation thereof, and pharmaceutical compositions containing the same
AU635758B2 (en) Thiazole derivatives, processes for production thereof and pharmaceutical compositions comprising the same
ZA90123B (en) 2-amino-pyrimidinone derivatives
HU9201213D0 (en) Pyrazolo-piridin-derivatives and process for their production
HUT52099A (en) Process for producing antiviral tetrahydroimidazo/1,4/benzodiazepin-2-one derivatives and pharmaceutical compositions comprising such compounds as active ingredient
HUT64318A (en) Process for production benzodpyrane derivativs and pharmaceutical preparations containing these compounds as effective substance
NO174886C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive pyrrolidin-derivater
NO176608C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive 3-piperidinylindazol-derivater
TW275629B (sv)
EP0306863A3 (en) New cephem compounds and processes for preparation thereof
EP0272849A3 (en) Use of 2-oxo-imidazolidine derivatives in the treatment of kidney diseases

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)